Indirect Treatment Comparison of Riociguat Replacement Therapy and Selexipag Add-on Therapy in Patients With Pulmonary Arterial Hypertension: Results From a Systematic Review

Background: Despite standard combination therapy with endothelin receptor antagonists (ERAs) and phosphodiesterase-5 inhibitors (PDE5is), many patients with pulmonary arterial hypertension (PAH) show inadequate therapeutic responses. Riociguat (a soluble guanylate cyclase stimulat...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ji-Eun An, Jahyun Cho, Min Ju Kim, Ah-Yeon Lee, Woo-Jeong Sim, Gyeong-U Hong, Soo Hyun Lee, Dong-Sook Kim, Sun-Young Yi, Kyung-Min Lee, Su-Yeon Yu
Format:	Artigo
Idioma:	Inglês
Publicat:	IMR Press 2026-05-01
Col·lecció:	Reviews in Cardiovascular Medicine
Matèries:	pulmonary hypertension riociguat selexipag systematic review comparative effectiveness research
Accés en línia:	https://www.imrpress.com/journal/RCM/27/5/10.31083/RCM46524
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!